Synapticure, Inc.
Publicly observedKenilworth, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Kenilworth | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Synapticure, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | G9QUJCDRVYB7 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant9 May 2025Publicly observed
NIH SBIR/STTR award: 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development
USD 1,246,192.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant9 May 2025Publicly observed
NIH SBIR/STTR award: 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development
USD 1,253,527.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.